When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Common warts

Last reviewed: 7 Aug 2025
Last updated: 30 Oct 2024

Summary

Definição

História e exame físico

Principais fatores diagnósticos

  • presence of risk factors
  • lesion growth over weeks to months
  • round, raised papule
  • tiny black dots on surface of lesion
Detalhes completos

Outros fatores diagnósticos

  • satellite lesions
  • fingers or nail fold lesions
  • facial lesions
  • fissuring
  • hyperkeratosis
  • grayish-white or light brown color
  • filiform papule with sharp spikes
Detalhes completos

Fatores de risco

  • water immersion
  • occupations involving handling of meat or fish
  • nail biting
  • age under 35 years
  • immunocompromised
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • no initial test
Detalhes completos

Investigações a serem consideradas

  • skin biopsy
  • immunoperoxidase stain
  • skin culture
Detalhes completos

Algoritmo de tratamento

AGUDA

common wart: immunocompetent

common wart: immunocompromised

filiform wart

Colaboradores

Autores

Angela Yen Moore, MD

Director

Arlington Center of Dermatology

Primary Investigator

Arlington Research Center

Arlington

Clinical Assistant Professor

Baylor University Medical Center

Dallas

Clinical Assistant Professor

University of Texas Medical Branch

Galveston

TX

Declarações

Dr. Moore receives funds as an advisory board member (A), consultant (C), clinical study investigator (I), and speaker (SP) – for Abbvie (I,SP), Almirall (C,I,SP), Arcutis (I), Biofrontera (C,I), Boehringer Ingelheim (I), Bristol-Myers Squibb (C,I), Dermavant (I), DS Biopharma (I), Eli Lilly (I), EpiHealth (A), Evolus (A), Galderma (I), Incyte (I), Janssen (I), Leo (A,SP), Mayne Pharma (C,I), Nimbus (I), Novartis (I), Parexel (I), Pfizer (I,SP), UCB (I), Verrica (I), Vyne (I,SP).

Agradecimentos

Dr Angela Yen Moore would like to gratefully acknowledge Dr Leonid Izikson, the previous contributor to this topic. LI declares that he has no competing interests.

Revisores

Brenda L. Pellicane, MD

Dermatologist

Wayne State University School of Medicine

Department of Dermatology

Detroit

MI

Declarações

BLP declares that she has no competing interests.

David Cassarino, MD, PhD

Assistant Professor

Department of Pathology and Laboratory Medicine

University of California

Los Angeles

CA

Declarações

DC declares that he has no competing interests.

Jashin J. Wu, MD

Chief Dermatology Resident

University of California

Irvine

CA

Declarações

JJW declares that he has no competing interests.

Sam Gibbs, FRCP

Consultant Dermatologist

Dermatology Department

The Great Western Hospital

Swindon

UK

Declarações

SG declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006;4:273-293.Texto completo  Resumo

Gibbs S, Harvey I, Sterling J, et al. Local treatments for cutaneous warts: systematic review. BMJ. 2002;325:461.Texto completo  Resumo

Kwok CS, Gibbs S, Bennett C, et al. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012;(9):CD001781.Texto completo  Resumo

Dall'oglio F, D'Amico V, Nasca MR, et al. Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2012;13:73-96. Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Common warts images
  • Diagnósticos diferenciais

    • Flat warts
    • Palmoplantar warts
    • Seborrheic keratosis
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV
    • Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV​​
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Warts

    HPV (human papillomavirus) vaccine

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal